Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection

April 9, 2017 at 7:23 pm

Journal of Clinical Microbiology February 2016 V.54 N.2 P.265-273                 

Minireviews

Gavin Cloherty, Andrew Talal, Kelly Coller, Corklin Steinhart, John Hackett Jr., George Dawson, Juergen Rockstroh, and Jordan Feld

aAbbott Diagnostics, Abbott Park, Illinois, USA

bUniversity at Buffalo, Buffalo, New York, USA

cViiV Healthcare, Research Triangle Park, North Carolina, USA

dUniversity Bonn, Bonn, Germany

eUniversity of Toronto, Toronto, Canada

The drugs available for the treatment of hepatitis C virus (HCV) have evolved to provide shorter treatment duration and higher rates of sustained virologic response (SVR), and the role of HCV infection diagnostic tests has had to evolve in order to meet changing clinical needs. This review gives an overview on the role of HCV infection diagnostic testing (molecular and serological tools) used in the diagnosis and management of HCV infection. All of this critical information guides physician decisions to optimize patient clinical outcomes. Also discussed is the future direction of diagnostic testing in the context of further advances in drug development.

PDF

http://jcm.asm.org/content/54/2/265.full.pdf

Advertisements

Entry filed under: Biología Molecular, Epidemiología, Hepatitis C, Infecciones virales, Metodos diagnosticos, REVIEWS, Update.

Epidemiología de la infección por grampositivos resistentes Atypical Presentation of Disseminated Zoster in a Patient with Rheumatoid Arthritis.


Calendar

April 2017
M T W T F S S
« Mar   May »
 12
3456789
10111213141516
17181920212223
24252627282930

Most Recent Posts


%d bloggers like this: